Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement | MicrobiomeTrials← Back to trialsNCT05727176
Study of Futibatinib in Patients With Advanced Cholangiocarcinoma With FGFR2 Fusion or Rearrangement
RecruitingPHASE2INTERVENTIONAL
Trial Details
Start: 2023-07-05Est. Completion: 2026-12
Enrollment target: 120 participants Locations- University of California San Diego UCSD - Moores Cancer Center, La Jolla, California, United States
- Tampa General Hospital Cancer Institute, Tampa, Florida, United States
- Henry Ford Health System, Detroit, Michigan, United States
- Gabrail Cancer Center Research, Canton, Ohio, United States
- Texas Oncology, Abilene, Texas, United States
- The Liver Institute at Methodist Dallas Medical Center, Dallas, Texas, United States
- Texas Oncology Methodist DFW, Dallas, Texas, United States
- Texas Onc Methodist (Charlton), Dallas, Texas, United States
- Texas Oncology - Northeast, Denton, Texas, United States
- Center for Oncology and Blood Disorders, Houston, Texas, United States
- Hospital Britanico, Buenos Aires, Argentina
- CEMIC, CABA, Argentina
- Sanatorio de la Mujer, Rosario, Argentina
- St Vincent's Hospital Sydney - The Kinghorn Cancer Centre, Sydney, New South Wales, Australia
- Alfred Health, Medical Oncology Unit, Second floor William Buckland Radiotherapy Center, Melbourne, Victoria, Australia
- St John of God Subiaco Hospital, Subiaco, Western Australia, Australia
Other microbiome trials you might be interested in
FGFR2 Gene Fusion/RearrangementOther Solid Tumors, Adult
The goal of this clinical trial is to evaluate if lirafugratinib is efficacious and safe to treat adult patients with pr…
Phoenix, United StatesEst. completion Sep 2027
Advanced/Metastatic Cancer
This is a nonrandomized, open-label, multicenter rollover study for patients who received futibatinib as monotherapy or …
San Francisco, United StatesEst. completion Apr 2027
Instituto do Cancer do Estado de Sao Paulo, Cerqueira César, BrazilIOP - Instituto de Oncologia do Parana, Curitiba, BrazilHospital Erasto Gaertner, Curitiba, BrazilHospital de Base de Sao Jose do Rio Preto, São José do Rio Preto, BrazilFundacao Antonio Prudente - A.C.Camargo Cancer Center, São Paulo, BrazilSunnybrook Health Sciences Center, Toronto, Ohio, CanadaGrand River Hospital - Grand River Regional Cancer Centre (GRRCC), Kitchener, OH, CanadaUniversity of Toronto, Toronto, OH, CanadaMcGill University Health Center, Montreal, Quebec, CanadaGuangdong Provincial People's Hospitall, Guangzhou, Guangdong, ChinaHarbin Medical University - Cancer Hospital, Harbin, Heilongjiang, ChinaJiangsu Provance Hospital, Nanjing, Jiangsu, ChinaJilin Cancer Hospital, Changchun, Jilin, ChinaShandong University - Shandong Cancer Hospital, Jinan, Shandong, ChinaZhongahan Hospital Fudan unversity, Shanghai, Shanghai Municipality, ChinaWest China Hospital- Sichuan University, Chengdu, Sichuan, ChinaSir Run Run Shaw Hospital, Zhejiang University, Hangzhou, Zhejiang, ChinaShanghai Gobroad Cancer Hospital China Pharmaceutical University, Shanghai, ChinaTongji University Shanghai East Hospital, Shanghai, ChinaThe University of Hong Kong, Hong Kong Island, Hong KongThe Chinese University of Hong Kong Prince of Wales Hospital, New Territories, Hong KongPoliclinico S. Orsola-Malpighi, Bologna, ItalyIRCCS Humanitas Research Hospital, Rozzano, ItalyAOUI Verona - Ospedale Borgo Roma, Verona, ItalyTohoku University Hospital, Sendai, Miyagi, JapanNational Cancer Center Hospital East, Kashiwa-Shi, JapanNagasaki University Hospital, Nagasaki, JapanNagoya University Hospital, Nagoya, JapanOsaka Metropolitan University Hospital, Osaka-Fu, JapanSzpital Wojewdzki w Koszalinie im. Mikoaja Kopernika, Koszalin, PolandCentrum Onkologii Ziemi Lubelskiej im. w. Jana z Dukli, Lublin, PolandEuropejskie Centrum Zdrowia Otwock Sp. Z.o.o., Otwock, PolandCentrum Onkologii-Instytut im. Marii Skłodowskiej - Curie, Warsaw, PolandFundação Champalimaud, Lisbon, PortugalCentro Hospitalar Lisboa Norte CHLN EPE - Hospital de Santa Maria, Lisbon, PortugalInje University Haeundae Paik Hospital, Busan, South KoreaDong-A University Hospital, Busan, South KoreaKyungpook National University Hospital, Daegu, South KoreaGyeongsang National University Hospital, Jinju, South KoreaCHA Bundang Medical Center, Seongnam, South KoreaYonsei University Health System - Severance Hospital, Seoul, South KoreaThe Catholic University of Korea, St. Mary's Hospital, Seoul, South KoreaHospital Vall d'Hebron, Barcelona, SpainInstitut Català d'Oncologia de l'Hospitalet de Llobregat - Hospital Duran i Reynals, Barcelona, SpainHospital General Universitario Gregorio Maranon, Madrid, SpainClinica Universidad de Navarra, Medical Oncology Service (Mariano Ponz Sarvise), Madrid, SpainHospital Universitario Fundación Jimenez Díaz, Madrid, SpainHospital Universitario 12 de octubre, Madrid, SpainClinica Universidad de Navarra, Pamplona, Spain